First Time Loading...

PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 29.55 CHF 1.9%
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

PPGN Price Targets Summary
PolyPeptide Group AG

Wall Street analysts forecast PPGN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PPGN is 22.23 CHF with a low forecast of 16.36 CHF and a high forecast of 31.5 CHF.

PPGN Lowest Forecast
Wall Street Target
16.36 CHF
45% Downside
PPGN Average Forecast
Wall Street Target
22.23 CHF
25% Downside
PPGN Highest Forecast
Wall Street Target
31.5 CHF
7% Upside
Lowest
Price Target
16.36 CHF
45% Downside
Average
Price Target
22.23 CHF
25% Downside
Highest
Price Target
31.5 CHF
7% Upside
PolyPeptide Group AG Competitors:
Price Targets
ABSI
Absci Corp
73% Upside
MRVI
Maravai LifeSciences Holdings Inc
12% Upside
ILMN
Illumina Inc
32% Upside
HVO
hVIVO PLC
31% Upside
ABSI
Absci Corp
73% Upside
MRVI
Maravai LifeSciences Holdings Inc
12% Upside
ILMN
Illumina Inc
32% Upside
HVO
hVIVO PLC
31% Upside
AZTA
Azenta Inc
28% Upside
SFZN
Siegfried Holding AG
19% Upside
TECH
Bio-Techne Corp
6% Upside
M
300463
Maccura Biotechnology Co Ltd
44% Upside

Revenue
Forecast

Revenue Estimate
PolyPeptide Group AG

For the last 4 years the compound annual growth rate for PolyPeptide Group AG's revenue is 12%. The projected CAGR for the next 3 years is 17%.

12%
Past Growth
17%
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
PolyPeptide Group AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
PolyPeptide Group AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
What are analyst estimates?

See Also

Summary
PPGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
PPGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PPGN stock valuation using valuation multiples.
Wall Street Estimates
PPGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PPGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PPGN's stock price target?
Price Target
22.23 CHF

According to Wall Street analysts, the average 1-year price target for PPGN is 22.23 CHF with a low forecast of 16.36 CHF and a high forecast of 31.5 CHF.

What is PolyPeptide Group AG's Revenue forecast?
Projected CAGR
17%

For the last 4 years the compound annual growth rate for PolyPeptide Group AG's revenue is 12%. The projected CAGR for the next 3 years is 17%.

ALPHA SPREAD
Join more than 134,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.